Table 5.
Multivariable Logistic Regression of Estradiol (E2) for Risks of Osteoporosis/Osteopenia in Men, Postmenopausal Women and All T2DM. Patients
| OR | 95% CI | P value | |
|---|---|---|---|
| Men (n = 149)† | |||
| Unadjusted | 0.981 | 0.971–0.992 | <0.001* |
| Adjusted | 0.980 | 0.968–0.992 | 0.001* |
| Postmenopausal Women (n = 102)† | |||
| Unadjusted | 0.983 | 0.967–0.999 | 0.048* |
| Adjusted | 0.986 | 0.966–1.006 | 0.176 |
| All (n = 251)‡ | |||
| Unadjusted | 0.986 | 0.980–0.992 | <0.001* |
| Adjusted | 0.983 | 0.972–0.993 | 0.001* |
Notes: * p<0.05, †Multivariable logistic regression was adjusted for age, smoking habit, alcohol consumption.
Abbreviations: BMI, diabetes duration, FBG, HbA1c, diabetes medical treatment, total cholesterol, triglycerides, HDL-C, LDL-C, creatinine, and uric acid. ‡Multivariable logistic regression was adjusted for sex, age, smoking habit, alcohol consumption, BMI, diabetes duration, FBG, HbA1c, diabetes medical treatment, total cholesterol, triglycerides, HDL-C, LDL-C, creatinine, and uric acid; CI, confidence interval; OR, odds ratio.